News & Media

Take a closer look at what we’re doing across Teva worldwide

Press releases
Nov 5 / 2020
Teva Reports Third Quarter 2020 Financial Results
Read more
Oct 21 / 2020
Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio
Read more
Oct 7 / 2020
Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfrm) Injection Published in Headache
Read more
Oct 2 / 2020
Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) and ATRIPLA® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) Tablets in the U.S.
Read more
Top Stories
Read the latest Teva news
‘I’ve seen the impact that asthma and COPD can have.’

Xinyu Liu develops Teva’s digital products and devices to help both patients and healthcare professionals. Here she explains why her role is an unusual one in a pharmaceutical company, why she sees her job as being an advocate for patients, and how her personal connection to asthma and COPD has fuelled her passion to work in this industry.

Read more
“Half the world’s people lack access to medicines.”

Giancarlo Francese works to helps improve access to medicines for some of the world’s poorest people. His job is a challenging one: to help improve the health of millions of people – as quickly as possible. Here he discusses an important campaign to get cancer drugs to children in Malawi, and how the death of a childhood friend influenced his decision to pursue a career in the health industry.

Read more
Our Commitment to HIV

For years, Teva has supported patients living with HIV and we continue to do so by delivering quality, cost-effective treatment options to patients. Let’s look at some facts.

Read more
Global Diversity Awareness Month

Teva is commemorating Diversity Awareness Month by sharing perspectives from our Employee Resource Group (ERG) leadership  


Read more